14 studies found for:    jtt-705
Show Display Options
Download search resultsDownload the search results for:
jtt-705 (14 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
Condition: Type II Hyperlipidemia
Interventions: Drug: JTT-705 600 mg and pravastatin 40 mg;   Drug: JTT-705 300 mg and pravastatin 40 mg;   Drug: Placebo and pravastatin 40 mg
2 Completed Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
Condition: Type II Hyperlipidaemia
Interventions: Drug: Placebo;   Drug: JTT-705 300mg;   Drug: JTT-705 600mg;   Drug: JTT-705 900mg
3 Completed Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Condition: Dyslipidemia
Interventions: Drug: JTT-705 600 mg and simvastatin 40 mg;   Drug: Placebo and simvastatin 40 mg
4 Completed Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Condition: Dyslipidemia
Interventions: Drug: JTT-705 600 mg and atorvastatin 20 mg;   Drug: Placebo and atorvastatin 20 mg
5 Completed A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: atorvastatin;   Drug: dalcetrapib
6 Completed A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Condition: Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Interventions: Other: Background care;   Drug: Placebo;   Drug: dalcetrapib
7 Completed A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib;   Drug: placebo
8 Terminated A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Condition: Cardiovascular Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
9 Completed A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers
Condition: Healthy Volunteer
Intervention: Drug: dalcetrapib
10 Completed A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib;   Drug: Placebo;   Drug: Evidence-based medical care for Acute Coronary Syndrome
11 Completed A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
12 Completed A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
13 Completed A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
14 Completed A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib

Indicates status has not been verified in more than two years